GSK-111535



Immunogenicity and reactogenicity study of GlaxoSmithKline Biologicals' Infanrix™/Hib vaccine administered as a booster dose to 18-24 months old children
Diphtheria, Tetanus, Acellular Pertussis Vaccine Adsorbed
111535
NCT00696423
Acellular pertussis; Diphtheria; Tetanus
Phase 3
 
May 2013